Latest news

Hospitals sought for Valsartan study

Can Valsartan prevent serious accumulation of fluid in the lungs in COVID-19? To answer this question, the Dutch Cardiovascular Alliance started the Praetorian COVID study. Initiators and research leaders Niels van Royen and Roland van Kimmenade (Radboudumc) are urging colleagues from other hospitals to participate.

COVID-19 research: avoid duplication

Avoid duplication, combine efforts, maximise results, register your COVID-studies now

DCVA supports studies

Given the strong correlation and potentially deadly entanglement of COVID-19 and cardiovascular diseases, the DCVA decided to support two research studies

Strategy meeting 

How nephrology and cardiology share common goals, what COVID-19 teaches us about working together with fifteen partners, three dilemmas and no socialising during drinks and dinner: those were the highlights of our first online but vivid strategy meeting on 1 April.

Meet the partners

In this fifth edition of Meet the partners we interview Niek Dubelaar LLM MSc (left), Head of Knowledge Transfer Office of KNAW and Dr. ir. Herry Nijhuis (right), Director NWO Applied and Engineering Sciences (TTW).

CAPACITY COVID REGISTRY

COVID-19 patients with cardiovascular disease are an extremely vulnerable population. To give these patients the best possible care and to be prepared for future outbreaks, we need to know more about these patients and the best practices for treating them. Therefore DCVA partners launched the CAPACITY COVID Registry.

DCVA & RegMedXB fund launched

Launch of fund to accelerate development of solutions for prevention and cure of chronic diseases ensuring patients benefit earlier

Lukas Dekker

There is much to be achieved with technology in the area of prevention, earlier detection and better treatment. The brand new professor Lukas Dekker wants to be the first DCVA ambassador to build bridges between cardiologists and technologists.

Start of the Leadership Program

Recently a group of talents has been selected as the future leaders in the cardiovascular arena. They are subject of the first edition of the DCVA Leadership Program.

Five million awarded to six projects in first DCVA call

In light of the first DCVA call ‘Heart for sustainable care’, six research teams received a total of over five million euros for research into the use of new technology against cardiovascular diseases.

Centralisation Dutch figures on CV disease

Data on cardiovascular disease in the Netherlands can be found in various places. The DHF and NHR joined forces and launched their new website to centralise all these data

Intensification of cooperation DHF, NVVC, Harteraad in the context of the DCVA

Early detection of heart failure, atrial fibrillation and chest pain and the best treatment, tailored to patients' personal needs. To achieve this, the four partners will collaborate even more intensively in the coming three years

Meet the partners

In this fourth edition of Meet the partners we interview Dirk Jan Duncker, ambassador and former board member of the Netherlands Heart Institute, and Radjesh Manna, director of programs at ZonMw.

The Dutch Cardiology Concert in the Royal Concertgebouw

Do you have a heart full of music? Register now, to play at the Cardiology Concert in the Royal Concert Hall en Amsterdam. Organised bij de NVVC and WCN.

Rob de Ree

Why is valorisation so important? What can be accomplished with the acquired 8 million? What will be the first steps? We ask Rob de Ree, chair of valorisation

Meet the partners

In this third edition of Meet the partners we interview Fabrice Martens, President of WCN, and Carmen van Vilsteren, Chair of Top Sector Life Sciences & Health (Health~Holland).

€8 million impulse for regenerative and cardiovascular medicine

Prof. Dr. Jolanda van der Velden

What inspired Jolanda van der Velden to initiate the DCVA Leadership Program. What's so special about the program, and who is the DCVA looking for? Read the interview and find out.

Vote now

The Agenda identifies 15 challenges and Opportunities for Cardiovascular Disease Research. Vote now to prioritize these subjects!

Robert Tieleman chair of Implementation

Cardiologist Robert Tieleman has recently been appointed as chair of implementation. We interviewed him on his vision on implementation, and the role of different parties involved